
NeuroOne Medical Technologies Corporation (NMTC) Q2 2026 Earnings Call Transcript
NeuroOne Medical Technologies Corporation (NMTC) Q2 2026 Earnings Call Transcript
Seeking Alpha5/12/2026Neutral
NeuroOne Medical Technologies Corporation is a medical technology company. The company is headquartered in Eden Prairie, Minnesota.
| Revenue (TTM) | $12.47M |
| Gross Profit (TTM) | $3.29M |
| EBITDA | $-7.66M |
| Operating Margin | -122.90% |
| Return on Equity | -124.70% |
| Return on Assets | -58.10% |
| Revenue/Share (TTM) | $1.47 |
| Book Value | $0.43 |
| Price-to-Book | 4.75 |
| Price-to-Sales (TTM) | 1.37 |
| EV/Revenue | 1.692 |
| EV/EBITDA | -2.10 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 16.30% |
| Shares Outstanding | $9.11M |
| Float | $6.11M |
| % Insiders | 25.23% |
| % Institutions | 22.45% |
Volatility is currently expanding

NeuroOne Medical Technologies Corporation (NMTC) Q2 2026 Earnings Call Transcript
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on NMTC and any ticker you trade — then tracks every position and per-strategy win rate.